NCT06188715 - Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

August 5, 2024

Study Completion Date

August 5, 2024

Conditions

TrichuriasisAscariasisHookworm Infections

Interventions

DRUG

Moxidectin 2 mg Oral Tablet

Tablets of 2 mg moxidectin

DRUG

Albendazole 400 mg Oral Tablet

Tablets of 400 mg albendazole

DRUG

Placebo Moxidectin

Placebo tablets for moxidectin

DRUG

Placebo Albendazole

Placebo tablets for albendazole

Trial Locations (1)

Public Health Laboratory Ivo de Carneri, Chake Chake

All Listed Sponsors

collaborator

Public Health Laboratory Ivo de Carneri

OTHER

lead

Jennifer Keiser

OTHER